Viyash Scientific Limited (SEQUENT) — Capital Reinvestment Ratio
Latest as of September 2025:
0.36x
Viyash Scientific Limited (SEQUENT) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs449.00 Million) in capital expenditures (Rs161.00 Million). See free cash flow generation of Viyash Scientific Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.36x
Capex / Operating Cash Flow
Operating Cash Flow
Rs449.00 Million
INR
Capital Expenditures
Rs161.00 Million
INR
Data as of
Sep 2025
Most recent filing
Viyash Scientific Limited Capital Reinvestment Ratio (2006–2025)
This chart tracks Viyash Scientific Limited's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Viyash Scientific Limited (2006–2025)
Year-by-year Capital Reinvestment Ratio for Viyash Scientific Limited from 2006 to 2025. For live market cap and broader valuation context, see SEQUENT market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | Rs833.60 Million | Rs390.90 Million | ▼ -53.4% |
| 2024 | 1.01x | Rs305.95 Million | Rs308.07 Million | ▼ -80.4% |
| 2023 | 5.13x | Rs168.08 Million | Rs861.79 Million | ▲ +383.2% |
| 2022 | 1.06x | Rs305.95 Million | Rs324.64 Million | ▲ +130.5% |
| 2021 | 0.46x | Rs1.15 Billion | Rs528.30 Million | ▲ +30.4% |
| 2020 | 0.35x | Rs1.15 Billion | Rs407.22 Million | ▲ +61.0% |
| 2019 | 0.22x | Rs1.16 Billion | Rs254.45 Million | ▼ -78.9% |
| 2018 | 1.04x | Rs452.39 Million | Rs470.22 Million | ▼ -61.6% |
| 2012 | 2.71x | Rs302.36 Million | Rs818.66 Million | ▲ +134.6% |
| 2011 | 1.15x | Rs506.60 Million | Rs584.73 Million | ▼ -21.8% |
| 2010 | 1.48x | Rs168.95 Million | Rs249.31 Million | ▲ +564.9% |
| 2006 | 0.22x | Rs72.43 Million | Rs16.07 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow